Differences in quality of life, medication adherence and perception of quality of life by PHE-s and ACE measure scores
Questionnaire (median (IQR)) | Patient engagement level (PHE-s) | Patient engagement level (ACE measure) | ||||
High (n=428) | Low (n=231) | P value** | High (n=369) | Low (n=290) | P value** | |
Quality of life (EQ-5D-3L) | ||||||
Mobility | 1.0 (1.0–2.0) | 2.0 (1.0–2.0)† | <0.001* | 1.0 (1.0–2.0) | 2.0 (1.0–2.0)† | <0.001* |
Self-care | 1.0 (1.0–1.0) | 1.0 (1.0–2.0)† | <0.001* | 1.0 (1.0–1.0) | 1.0 (1.0–2.0)† | <0.001* |
Usual activities | 1.0 (1.0–2.0) | 2.0 (1.0–2.0)† | <0.001* | 1.0 (1.0–2.0) | 2.0 (1.0–2.0)† | <0.001* |
Pain/discomfort | 1.0 (1.0–2.0) | 2.0 (1.0–2.0)† | <0.001* | 2.0 (1.0–2.0) | 2.0 (1.0–2.0)† | 0.023* |
Anxiety/depression | 1.0 (1.0–2.0) | 2.0 (2.0–2.0)† | <0.001* | 1.0 (1.0–2.0) | 2.0 (1.0–2.0)† | 0.002* |
VAS | 74.0 (60.0–85.0)† | 50.0 (45.0–65.0) | <0.001* | 70.0 (50.0–80.0)† | 60.0 (50.0–75.0) | <0.001* |
Medication adherence (MARS-5) | 24.0 (23.0–25.0)† | 24.0 (22.0–25.0) | 0.007* | 24.0 (22.0–25.0) | 24.0 (22.0–25.0) | 0.224 |
Perception of quality of care (HCCQ) | 5 (3.7–6.3)† | 4.0 (2.7–5.8) | <0.001* | 5.0 (3.7–6.3)† | 4.2 (3.0–5.8) | <0.001* |
*Statistically significant.
**Mann‒Whitney U test was performed.
†Scale/subscale scores are significantly higher than those of the other group.
eVAS, visual analogue scale; HCCQ, Health Care Climate Questionnaire; MARS-5, Medication Adherence Report Scale; PHE-s, Patient Health Engagement Scale.